Raxone
Raxone is a medicine authorised by Swissmedic under authorisation number 68063. The authorisation holder is Chiesi SA. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 01 March 2024 and the authorisation is limited until 28 February 2029. ATC code N06BX13 places the medicine in the group Psychoanaleptics.
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Raxone, comprimé pelliculé | B | 01 March 2024 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 180 | Tablette(n) | N06BX13 | 01.99.0. | B |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Raxone authorised in Switzerland?
Yes. Raxone is authorised by Swissmedic under authorisation number 68063, data as of 01 September 2026. The authorisation is limited until 28 February 2029.
Which dispensing category does Raxone have?
Raxone is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Raxone?
The authorisation holder is Chiesi SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.